2810
H. Gu€zlek et al. / Carbohydrate Research 340 (2005) 2808–2811
structure of the biosynthetic intermediate.3a Except for
the signal of C-6, the 13C NMR signals of the heptopyr-
anosyl unit are nearly identical to those of the related
L-glycero-D-manno-heptose 7-phosphate, thus fully con-
firming the structural assignments.7
In conclusion, the method reported herein constitutes
a short and efficient strategy for the synthesis of heptose
7-phosphates.
phase was dried (MgSO4) and concentrated. The residue
was purified by column chromatography (1:1, toluene–
diethyl ether) to give 2 as a colourless syrup (815 mg,
65%); ½aꢁD +26 (c 1.0, CHCl3); H NMR (CDCl3): d
7.36–7.25 (m, 15H, Ph), 5.85 (dd, 1H, J6,5 10.8, J5,4
1.3 Hz, H-5), 5.79 (ddd, 1H, J6,7a = J6,7b 2.3 Hz, H-6),
5.05 (s, 1H, H-1), 5.09–4.94 (m, 4H, CH2Ph), 4.71–
20
1
4.59
(m,
5H,
H-4,
H-7a,
H-7b,
H-2,
H-3), 4.65 and 4.47 (AB system, 2H, JA,B 11.9 Hz,
CH2Ph), 1.43 and 1.27 [s, each 3H, C(CH3)2]; 13C
NMR (CDCl3): d 137.22 (Ph), 135.83 and 135.74 (C-5,
C-6), 128.71–127.42 (Ph), 112.56 [C(CH3)2], 105.32
(C-1), 85.29 (C-3), 81.35 (C-2), 75.61 (C-4), 69.31,
69.24 and 69.05 (CH2Ph), 63.55 (JC,P 5.3 Hz, C-7),
26.04 and 24.77 [C(CH3)2]; 31P NMR (CDCl3): d 0.05.
Anal. Calcd for C31H35O8P: C, 65.72; H, 6.23. Found:
C, 65.47; H, 6.60.
1. Experimental
1.1. General
All solvents were purified and dried by standard proce-
dures. Column chromatography was performed on Silica
Gel 60 (230–400 mesh, E. Merck). Desalting was per-
formed on PD-10 desalting column containing Sepha-
dexTM G-25. Analytical TLC was performed using Silica
Gel 60 F254 HPTLC plates with 2.5 cm concentration
zone (E. Merck). Spots were detected by treatment with
anisaldehyde–H2SO4. Optical rotations were measured
with a Perkin–Elmer 243 B polarimeter. NMR spectra
were recorded at 297 K in D2O and CDCl3 with a Bruker
DPX 300 spectrometer (1H at 300.13 MHz, 13C at
75.47 MHz and 31P at 121.50 MHz) using standard Bru-
ker NMR software. 1H NMR spectra were referenced to
tetramethylsilane or 2,2-dimethyl-2-silapentane-5-sul-
fonic acid. 13C NMR spectra were referenced to chloro-
form for solns in CDCl3 (d 77.00) or dioxane (d 67.40)
for solns in D2O. 31P NMR spectra were referenced
externally to 85% aq H3PO4 (d 0.0). ESIMS data were
obtained on a Waters Micromass Q-TOF Ultima Global
instrument.
1.3. Benzyl 7-O-[bis(benzyloxy)phosphoryl]-2,3-O-isoprop-
ylidene-L-glycero-b-L-gulo-heptofuranoside (3) and benzyl
7-O-[bis(benzyloxy)phosphoryl]-2,3-O-isopropylidene-D-
glycero-a-D-manno-heptofuranoside (4)
A soln of 2 (815 mg, 1.44 mmol) and NMMO (388.7 mg,
2.88 mmol) in 2:1 dioxane–water (10 mL) and acetone
(3 mL) was stirred at rt. Then osmium tetraoxide
(1.5 mL, 0.12 mmol; 2% in water) was transferred into
the flask and the mixture was stirred for 5 h. The soln
was then diluted with CHCl3 (150 mL). After treatment
with ice-cold 5 M HCl (6 mL) the mixture was vigorously
shaken with 45% aq Na2S2O5 (9 mL) and water. The
organic phase was dried (MgSO4) and concentrated to
a syrupy residue (580 mg, 71%). D-glycero-a-D-manno-
Heptofuranoside (4) and the L-glycero-b-L-gulo diaste-
reoisomer 3 were separated by chromatography on silica
gel (2:3 n-hexane–EtOAc) to give 445 mg of 4 as colour-
less crystals, mp 82–83 ꢁC (hexane–EtOAc), Rf 0.62;
1.2. Benzyl 7-O-[bis(benzyloxy)phosphoryl]-5,6-dideoxy-
2,3-O-isopropylidene-a-D-lyxo-(Z)-hept-5-enofuranoside
(2)
20
½aꢁD +40 (c 0.9, CHCl3); 1H NMR (CDCl3): d 7.37–
7.26 (m, 15H, Ph), 5.12 (s, 1H, H-1), 5.10–5.04 (m, 4H,
3
3
Compound 1 (680 mg, 2.22 mmol) and bisbenzyloxy-
N,N-diisopropylaminophosphine (1.87 mL, 5.55 mmol)
were dried by repeated evaporation with dry toluene
(4 · 10 mL) and then under diminished pressure for 5 h.
Then CH2Cl2 (6 mL) was added to the sample. The flask
was charged with a soln of 1H-tetrazole (467 mg,
6.66 mmol) in dry MeCN (3 mL) and stirred at room
temperature for 2 h under Ar. Monitoring of the reac-
tion by TLC showed the formation of phosphite triesters
(7:3 toluene–EtOAc). The reaction mixture was cooled
to 0 ꢁC and a soln of t-BuOOH (617 lL, 3.33 mmol,
80% soln in di-tert-butyl peroxide) was gradually added.
The soln was stirred for 15 h at room temperature and
the solvent was evaporated using a stream of argon.
The residue was dissolved in 2:1 diethyl ether–EtOAc
(50 mL) and washed sequentially with satd NaHCO3–
water (until pH 9 was reached) and brine. The organic
POCH2Ph), 4.91 (dd, 1H, J3,2 6.0, J3,4 3.8 Hz, H-3),
4.70 (s, 2H, CH2Ph), 4.63 (d, 1H, H-2), 4.61 (dd, 1H,
3
J7a,7b 11.8, J7a,6 5.0 Hz, H-7a), 4.45 (m, 1H, H-7b),
3
3
4.16 (dd, 1H, J4,5 7.0 Hz, H-4), 4.01 (t, 1H, J5,6
3
7.0 Hz, H-5), 3.92 (m, 1H, J6,7b 3.0 Hz, H-6), 3.78 (br
s, OH), 1.44 and 1.30 [2s, 6H, C(CH3)2]; 13C NMR
(CDCl3): d 137.09 (Cquart. Ph), 128.65–126.99 (Ph),
112.70 [C(CH3)2], 105.46 (C-1), 84.73 (C-2), 80.44
(C-3), 79.03 (C-4), 72.87 (d, JC6,P 4.9 Hz, C-6), 69.75
(d, POCH2Ph), 69.35, 69.25 and 69.17 (C-5, C-7,
POCH2Ph), 65.36 (CH2Ph), 25.92 and 24.45 [C(CH3)2];
31P NMR (CDCl3):
d
1.14. Anal. Calcd for
C31H37O10P: C, 61.99; H, 6.21. Found: C, 61.46; H,
6.26.
Further elution furnished 3 as a syrup (115 mg), Rf
20
0.57; ½aꢁD +43 (c 1.3, CHCl3). 1H NMR (CDCl3): d
7.36–7.26 (m, 15H, Ph), 5.16 (s, 1H, H-1), 5.11–5.04